Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

A team from the Institute of Cancer Research, London, found NXP800 slowed the growth of prostate cancer cells, including ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

The Kremlin has been discussing Donald Trump's claims that a meeting between him and Vladimir Putin is being set up. Meanwhile, Russian elites are concerned with Vladimir Putin's efforts to wage a ...

But we'll be back tomorrow with more updates on the war in Ukraine. Here are the key lines from today: Outgoing US defence secretary Lloyd Austin announced a $500m (£407m) aid package for Ukraine ...

The Bank of Israel set the representative shekel-dollar rate down 0.248% from Monday, at NIS 3.627/$. Information ...

Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...